Professors Dean Fennell and Garteh Griffiths, co-lead investigators of the phase III CONFIRM trial, share the results of the study of nivolumab and discuss what these results mean for patients with relapsed mesothelioma.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
